Biogen (BIIB) PT Lowered to $221 at Mizuho
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Price: $197.74 -2.67%
Rating Summary:
27 Buy, 16 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 29
Rating Summary:
27 Buy, 16 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 29
Join SI Premium – FREE
Mizuho analyst Salim Syed lowered the price target on Biogen (NASDAQ: BIIB) to $221.00 (from $236.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Freedom Broker Upgrades Halliburton (HAL) to Hold
- Chocoladefabriken Lindt & Spruengli AG (LISN:SW) (LDSVF) PT Lowered to CHF112,000 at Kepler Cheuvreux
- Interactive Brokers Group (IBKR) PT Raised to $110 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
